Andrade Chittaranjan
Department of Psychiatry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India, Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India (
J Clin Psychiatry. 2025 Jan 6;86(1):24f15753. doi: 10.4088/JCP.24f15753.
Cannabis use during pregnancy is increasing; the study of adverse outcomes in cannabis-exposed pregnancies is therefore important. Previous articles in this series described increased risks of maternal adverse outcomes, fetal adverse outcomes, birth defects in newborns, and autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in childhood. This article examines neuropsychiatric adverse outcomes in offspring gestationally exposed to cannabis. Currently available research suggests that prenatal cannabis exposure is associated with increased risks of ASD, ADHD, psychosis proneness, psychotic like experiences, internalizing problems, externalizing problems, attention problems, thought-related problems, social problems, impaired executive function, and observed aggression. There is insufficient study of prenatal cannabis exposure and offspring IQ. Shortcomings in the existing literature are discussed; as examples, many outcomes were determined by screening rather than by formal assessment, prenatal cannabis exposure was ascertained retrospectively in some studies, childhood adverse experiences and exposures were seldom included as covariates, and details about cannabis use (source, potency, frequency, reasons) were unavailable. Curiously, the findings of adverse outcomes were inconsistent, and the effect sizes were small. Possible explanations are that women who use cannabis during pregnancy may not admit it and their pregnancy outcomes may then be misclassified into the control group, assessment of outcomes at too young an age or with insufficient accuracy may blur differences between exposed and unexposed groups, and adjustment for covariates may mask the full effects of cannabis. A last observation is that the studies reviewed were based on exposures that occurred decades ago. Given the increasing potency of currently available cannabis and the limitations of the existing research, it is possible that the available findings underestimate the breadth and severity of the risks. Cannabis is not a necessary substance for use during pregnancy, and so women who consider it safe might do well to guard against complacency and unnecessary exposure.
孕期大麻使用呈上升趋势;因此,研究孕期接触大麻的不良后果具有重要意义。本系列之前的文章描述了母亲不良后果、胎儿不良后果、新生儿出生缺陷以及儿童期自闭症谱系障碍(ASD)和注意力缺陷多动障碍(ADHD)风险的增加。本文探讨孕期接触大麻的后代的神经精神不良后果。目前可得的研究表明,产前接触大麻与ASD、ADHD、易患精神病、类精神病体验、内化问题、外化问题、注意力问题、思维相关问题、社交问题、执行功能受损以及观察到的攻击行为风险增加有关。关于产前接触大麻与后代智商的研究不足。讨论了现有文献的不足之处;例如,许多结果是通过筛查而非正式评估确定的,一些研究中产前接触大麻是通过回顾性确定的,儿童期不良经历和接触很少作为协变量纳入,并且关于大麻使用的细节(来源、效力、频率、原因)无法获取。奇怪的是,不良后果的研究结果不一致,效应量较小。可能的解释是,孕期使用大麻的女性可能不承认,其妊娠结局可能随后被错误分类到对照组,在太小的年龄或准确性不足的情况下对结局进行评估可能会模糊暴露组和未暴露组之间的差异,并且对协变量进行调整可能会掩盖大麻的全部影响。最后一点观察是,所审查的研究基于几十年前发生的接触情况。鉴于目前可得大麻的效力不断增加以及现有研究的局限性,现有研究结果有可能低估了风险的广度和严重性。大麻并非孕期使用的必需物质,因此,那些认为其安全的女性最好避免自满和不必要的接触。